Evotec Plans $300 Million Cash Sale of French Site to Sandoz

MT Newswires Live
07-30

Evotec (EVO) said Wednesday it signed a nonbinding agreement with Sandoz for the potential sale of the Just - Evotec Biologics EU site in Toulouse, France, for roughly $300 million in cash.

Under the proposed deal, Sandoz would assume full ownership of the site, with Evotec to retain economic upside via revenue, milestones and royalty optionality.

The deal terms include further technology-related consideration, future development revenue, milestones and product royalties, Evotec said.

The company's shares were up 4.5% in recent premarket activity.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10